A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
NCT00349427
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
256
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2
Interventions
DRUG:
Rosiglitazone 4 mg
Sponsor
GlaxoSmithKline